Immunoaffinity liquid chromatography-tandem mass spectrometry detection of nitrotyrosine in biological fluids: Development of a clinically translatable biomarker

Analytical Biochemistry

Volumn 380, Issue 1, 2008, Pages 68-76

  Radabaugh, Melissa R ^a   Nemirovskiy, Olga V ^a   Misko, Thomas P ^a   Aggarwal, Poonam ^a   Mathews, W Rodney ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

3 Nitrotyrosine; Biological fluids; Biomarker; Immunoaffinity; LC MS MS; Mass spectrometry

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; BIOMARKERS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NITRIC OXIDE; TRANSPORT PROPERTIES;

3-NITROTYROSINE; BIOLOGICAL FLUIDS; IMMUNOAFFINITY; LC-MS/MS; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY (LC MS/MS); LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; REACTIVE NITROGEN SPECIES; SENSITIVITY AND SPECIFICITY;

CEREBROSPINAL FLUID;

3 NITROTYROSINE; BIOLOGICAL MARKER; PEPTIDE; PRONASE;

AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; BODY FLUID; CEREBROSPINAL FLUID; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MALE; NITRATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SENSITIVITY AND SPECIFICITY; SYNOVIAL FLUID; TANDEM MASS SPECTROMETRY; URINE LEVEL;

ANIMALIA;

EID: 46649119509     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2008.05.019     Document Type: Article

References (34)

1. Kaur H., and Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation: Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 350 (1994) 9-12
2. Beckman J.S., Ye Y.Z., Anderson P.G., Chen J., Accavitti M.A., Tapey M.M., and White C.R. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe-Seyler 375 (1994) 81-88
3. Yamaguchi Y., Yoshikawa N., Kagota S., Nakamura K., Haginaka J., and Kunitomo M. Elevated circulating levels of oxidative-nitrative stress and inflammation in a genetic rat model of metabolic syndrome. Nitric Oxide 15 (2006) 380-386
4. Tohgi H., Abe T., Yamazaki K., Murata T., Ishizaki E., and Isobe C. Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Neurosci. Lett. 269 (1999) 52-54
5. Ischiropoulos H., Zhu L., Chen J., Tsai M., Martin J.C., Smith C.D., and Beckman J.S. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298 (1992) 431-437
6. Oshima H., Friesen M., Brouet I., and Bartsch H. Nitrotyrosine as a new marker for endogenous nitrosation and nitration of proteins. Food Chem. Toxicol. 28 (1990) 647-652
7. Shishehbor M.H., Aviles R.J., Brennan M.-L., Fu X., Goormastic M., Pearce G.L., Gokce N., Keaney Jr. J.F., Penn M.S., Sprecher D.L., Vita J.A., and Hazen S.L. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 89 (2003) 1675-1680
8. Khan J., Brennand D.M., Bradley N., Gao B., Bruckdorfer R., and Jacobs M. 3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem. J. 330 (1998) 795-801
9. Herce-Pagliai C., Kotecha S., and Shuker D.E.G. Analytical methods for 3-nitrotyrosine as a marker of exposure to reactive nitrogen species: A review. Nitric Oxide 2 (1998) 324-336
10. Crow J.P., and Ischiropoulos H. Detection and quantitation of nitrotyrosine residues in proteins: In vivo marker of peroxynitrite. Methods Enzymol. 269 (1996) 185-194
11. Sodum R.S., Akerkar S.A., and Fiala E.S. Determination of 3-nitrotyrosine by high-pressure liquid chromatography with a dual-mode electrochemical detector. Anal. Biochem. 280 (2000) 278-285
12. Shigenaga M.K., Lee H.H., Blount B.C., Christen S., Shigeno E.T., Yip H., and Ames B.N. Inflammation and NOx-induced nitration: Assay for 3-nitrotyrosine by HPLC with electrochemical detection. Proc. Natl. Acad. Sci. USA 94 (1997) 3211-3216
13. Hensley K., Maidt M.L., Pye Q.N., Stewart C.A., Wack M., Tabatabaie T., and Floyd R.A. Quantitation of protein-bound 3-nitrotyrosine and 3,4-dihydroxyphenylalanine by high-performance liquid chromatography with electrochemical array detection. Anal. Biochem. 251 (1997) 187-195
14. Richards D.A., Silva M.A., and Devall A.J. Electrochemical detection of free 3-nitrotyrosine: Application to microdialysis studies. Anal. Biochem. 351 (2006) 77-83
15. Kamisaki Y., Wada K., Nakamoto K., Kishimoto Y., Kitano M., and Itoh T. Sensitive determination of nitrotyrosine in human plasma by isocratic high-performance liquid chromatography. J. Chromatogr. B 685 (1996) 343-347
16. Crowley J.R., Yarasheski K., Leeuwenburgh C., Turk J., and Heinecke J.W. Isotope dilution mass spectrometric quantification of 3-nitrotyrosine in proteins and tissues is facilitated by reduction to 3-aminotyrosine. Anal. Biochem. 259 (1998) 127-135
17. Leeuwenburgh C., Hardy M., Hazen S., Wagner P., Oh-ishi S., Steinbrecher U., and Heinecke J.W. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272 (1997) 1433-1436
18. Petruzzelli S., Puntoni R., Mimotti P., Pulerà N., Baliva F., Fornai E., and Giuntini C. Plasma 3-nitrotyrosine in cigarette smokers. Am. J. Respir. Crit. Care Med. 156 (1997) 1902-1907
19. Yi D., Ingelse B.A., Duncan M.W., and Smythe G.A. Quantification of 3-nitrotyrosine in biological tissues and fluids: Generating valid results by eliminating artifactual formation. J. Am. Soc. Mass Spectrom. 11 (2000) 578-586
20. Hensley K., Maidt M.L., Pye Q.N., Stewart C.A., Wack M., Tabatabaie T., and Floyd R.A. Quantitation of protein-bound 3-nitrotyrosine and 3,4-dihydroxyphenylalanine by high-performance liquid chromatography with electrochemical array detection. Anal. Biochem. 251 (1997) 187-195
21. Tsikas D., Schwedhelm E., Stutzer F.K., Gutzki F.-M., Rode I., Mehls C., and Frölich J.C. Accurate quantification of basal plasma levels of 3-nitrotyrosine and 3-nitrotyrosinoalbumin by gas chromatography-tandem mass spectrometry. J. Chromatogr. B 784 (2003) 77-90
22. Söderling A.-S., Ryberg H., Gabrielsson A., Lärstad M., Torén K., Niari S., and Caidahl K. A derivatization assay using gas chromatography/negative chemical ionization tandem mass spectrometry to quantify 3-nitrotyrosine in human plasma. J. Mass Spectrom. 38 (2003) 1187-1196
23. Althaus J.S., Schmidt K.R., Fountain S.T., Tseng M.T., Carroll R.T., Galaltsis P., and Hall E.D. LC-MS/MS detection of peroxynitrite-derived 3-nitrotyrosine in rat microvessels. Free Radic. Biol. Med. 29 (2000) 1085-1095
24. Gaut J.P., Byun J., Tran H.D., and Heineke J.W. Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture negative chemical ionization gas chromatography and liquid chromatography-electrospray ionization tandem mass spectrometry. Anal. Biochem. 300 (2002) 252-259
25. Delatour T., Richoz J., Vuichoud J., and Stadler R.H. Artifactual nitration controlled measurement of protein-bound 3-nitro-l-tyrosine in biological fluids and tissues by isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry. Chem. Res. Toxicol. 15 (2002) 1209-1217
26. Frost M.T., Halliwell B., and Moore K.P. Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts. Biochem. J. 345 (2000) 453-458
27. Duncan M.W. A review of approaches to the analyses of 3-nitrotyrosine. Amino Acids 25 (2003) 351-361
28. Tsikas D., and Caidahl K. Recent methodological advances in the mass spectrometric analysis of free and protein-associated 3-nitrotyrosine in human plasma. J. Chromatogr. B 814 (2005) 1-9
29. Tsikas D. Quantitative determination of free and protein-associated 3-nitrotyrosine and S-nitrosothiols in the circulation by mass spectrometry and other methodologies: A critical review and discussion from the analytical and review point of view. In: Dalle-Donne I., Scaloni A., and Butterfield D.A. (Eds). Redox Proteomics: From Protein Modifications to Cellular Dysfunction and Diseases (2006), John Wiley, New York 287-341
30. Tsikas D. Affinity chromatography as a method for sample preparation in gas chromatography/mass spectrometry. J. Biochem. Biophys. Methods 49 (2001) 705-731
31. 18F]5-fluoro-3-nitro-l-tyrosine. J. Fluorine Chem. 121 (2003) 9-14
32. McCartney-Francis N.L., Song X.-Y., Mizel D.E., and Wahl S.M. Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease. J. Immunol. 166 (2001) 2734-2740
33. Pelletier J.-P., Jovanovic D.V., Lascau-Coman V., Fernandes J.C., Manning P.T., Connor J.R., Currie M.G., and Martel-Pelletier J. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: Possible link with the reduction in chondrocyte apoptosis and caspase 3 level. Arthritis Rheum. 43 (2000) 1290-1299
34. Stemmann O., Zou H., Gerber S.A., Gygi S.P., and Kirschner M.W. Dual inhibition of sister chromatid separation at metaphase. Cell 107 (2001) 715-726